Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
07/1998
07/29/1998EP0855443A2 cDNA clone HE8CH90 that encodes a 7-transmembrane receptor
07/29/1998EP0855182A1 3-Deoxyglucosone production inhibitor
07/29/1998EP0854721A1 Endothelin receptor antagonists
07/29/1998EP0854711A1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR
07/29/1998EP0854709A1 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity
07/29/1998EP0740668B1 Tetracyclic derivatives, process of preparation and use
07/29/1998CN1189151A 维生素d类似物 Vitamin d analogues
07/29/1998CN1039320C Method for preparing cyclohexane and octahydro-benzo (f) quinolinones and its optical isomer
07/28/1998US5786360 Antiallergens, central nervous system stimulants, diuretics, antihistamines, cardiotonic agents; water solubility
07/28/1998US5786347 Vitamin D amine and amide derivatives
07/28/1998CA2220851A1 Cdna clone he8ch90 that encodes a novel 7-transmembrane receptor
07/28/1998CA2141563C Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
07/23/1998WO1998031709A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
07/23/1998WO1998031660A1 Process for preparing indane-like compounds
07/23/1998WO1998031227A1 Novel cannabinoid receptor modulators
07/23/1998WO1998018493A3 Conjugates useful in the treatment of prostate cancer
07/23/1998DE19701607A1 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung Anitkörper that bind to the nidogen-binding domain of laminin, their preparation and use
07/23/1998CA2278477A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
07/23/1998CA2278424A1 Process for preparing indane-like compounds
07/23/1998CA2278307A1 Novel cannabinoid receptor modulators
07/22/1998EP0854191A2 Human cardiac/brain tolloid-like protein
07/22/1998EP0853945A1 Liquid gonadotropin containing formulations
07/22/1998EP0853942A2 Chimeric kidney
07/22/1998EP0853661A1 Specific binding members for human transforming growth factor beta; materials and methods
07/22/1998EP0853483A1 Novel peptides
07/22/1998EP0853479A1 ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS
07/22/1998EP0853477A1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
07/22/1998EP0677042B1 Selective ligands of 5ht1d-5ht1b receptors derived from indole-piperazine useful as medicaments
07/22/1998CN1187997A Drug for curing stone of urinary system
07/21/1998US5783576 Benzoyl guanidine derivatives, the preparation thereof and their use in pharmaceutical compositions
07/21/1998CA1339958C Isoferritin as a marker for pathological pregnancy
07/16/1998WO1998030683A2 Nuclear transfer with differentiated fetal and adult donor cells
07/16/1998WO1998030586A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
07/16/1998WO1998030560A1 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia
07/16/1998WO1998030556A1 Novel benzofuranone derivatives and process for producing the same
07/16/1998WO1998030240A1 Treatment of lupus nephritis with anti-cd40l compounds
07/16/1998CA2277910A1 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
07/16/1998CA2277222A1 Treatment of lupus nephritis with anti-cd40l compounds
07/15/1998EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor
07/15/1998EP0853084A2 Substituted purine derivatives as vitronectin receptor antagonists
07/15/1998EP0218717B1 Recombinant inhibin
07/15/1998CA2226803A1 Liquid gonadotropin containing formulations
07/14/1998US5780615 Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom
07/14/1998US5780592 Transplant, antitumor
07/14/1998US5780485 Administering adrenergic blocking agent; side effect reduction; fda orange book listed patent for silodosin
07/14/1998US5780471 Tricyclic benzazepine vasopressin antagonists
07/14/1998US5780438 Containing protein hydrolyzates; storage stable
07/14/1998US5780286 Arginase II
07/09/1998WO1998029123A1 Method of treating prostatic diseases using active vitamin d analogues
07/09/1998WO1998029119A1 Inhibitors of farnesyl-protein transferase
07/09/1998WO1998029105A2 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
07/09/1998WO1998028980A1 Inhibitors of farnesyl-protein transferase
07/09/1998CA2276465A1 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
07/09/1998CA2276150A1 Inhibitors of farnesyl-protein transferase
07/09/1998CA2276081A1 Inhibitors of farnesyl-protein transferase
07/08/1998EP0851925A1 Human growth hormone variants
07/08/1998EP0851769A1 Gene therapy using ovine adenoviral vectors
07/08/1998EP0730589B1 Isoxazoline compounds useful as fibrinogen receptor antagonists
07/08/1998CN1187132A Processed ginseng having enhanced pharmacological effect
07/08/1998CN1039008C Dual action inhibitors in angiotensin invertase and neutral endopeptidase
07/07/1998US5776964 Hypotensive agents; anticholesterol agents; cardiovascular disorders
07/07/1998US5776910 Dna molecule codes and fc receptors
07/07/1998US5776734 DNA encoding the β subunit of a mammalian maxi-K potassium channel
07/07/1998US5776503 Mixture of amino acids to minimize metabolic acidosis
07/07/1998US5776464 Administering heptocyte growth factor
07/07/1998CA2163446C Pyrazolopyrimidinones for the treatment of impotence
07/02/1998WO1998028292A1 Novel piperidine containing compounds
07/02/1998WO1998028276A1 Triarylethanes useful as pde iv inhibitors
07/02/1998WO1998028265A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
07/02/1998WO1998028264A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
07/02/1998WO1998027974A1 Antidiabetic agents
07/02/1998WO1998027973A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
07/02/1998CA2275681A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
07/02/1998CA2275665A1 Nitromethylthiobenzene derivatives as aldose reductase inhibitors
07/02/1998CA2275394A1 Antidiabetic agents
07/02/1998CA2219265A1 Human cardiac/brain tolloid-like protein
07/01/1998EP0850319A1 Method for modulating cell apoptosis
07/01/1998EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
07/01/1998EP0850236A1 Piperazino derivatives as neurokinin antagonists
07/01/1998EP0850059A1 Pharmaceutical formulations containing darifenacin
07/01/1998EP0814800A4 Water-based topical cream containing nitroglycerin; method of preparation and use thereof
07/01/1998CN1186515A 转化生长因子αHI Transforming growth factor αHI
07/01/1998CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
07/01/1998CN1186485A Pyrole derivatives and medicinal composition
07/01/1998CN1186431A Compositions and methods using nitroxides in combination with biocompatible macromolecules
07/01/1998CN1185948A Inhibitor for generation of 3-deoxyglucurone
07/01/1998CN1038937C Preparation of ergoline-8-carboxamides
07/01/1998CN1038931C Preparation of medicinal compositions useful as anta-gonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels
06/1998
06/30/1998US5773612 Indol-2-one derivatives
06/30/1998US5773530 Pyrazolopyridine adenosine antagonists
06/30/1998US5773440 Antiinflammatory agent
06/30/1998US5773436 Use of serotonin antagonists for treating fibromyalgia
06/30/1998US5773430 Reduces tissue destruction during inflammation resulting from the activity of human leukocyte elastase
06/30/1998US5773414 Endothelin antagonists
06/30/1998US5773032 Long-acting injection suspensions and a process for their preparation
06/30/1998CA2139947C Calcium channel blocking polypeptide from agelenopsis aperta
06/27/1998CA2225906A1 3-deoxyglucosone production inhibitor
06/25/1998WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors
06/25/1998WO1998027070A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
06/25/1998WO1998026782A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications